Myeloma Survival Rates

Multiple myeloma prognosis depends on the stage of the disease when it was diagnosed. Approximately, the median survival is: 

·         62 months for stage 1  

·         45 months for stage 2  

·         29 months for stages 3 

In addition, the prognosis differs from one race to another. According to the National Cancer Institute (NCI), the overall 5-year relative survival rate for 1999-2005 from 17 SEER geographic areas was 37.1%. Five-year relative survival rates by race and sex were:  

·         38.6% for white men;  

·         34.9% for white women;  

·         36.0% for black men;  

·         37.2% for black women. 

     Myeloma Treatment                                  Myeloma Prevention